📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Lipoxin A4 Attenuates Constitutive and TGF-ß1-Dependent Profibrotic Activity in Human Lung Myofibroblasts. (2015)

First Author: Roach KM

Attributed to: Resolving mediators as novel therapies for idiopathic pulmonary fibrosis funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.4049/jimmunol.1500936

PubMed Identifier: 26276873

Publication URI: http://europepmc.org/abstract/MED/26276873

Type: Journal Article/Review

Volume: 195

Parent Publication: Journal of immunology (Baltimore, Md. : 1950)

Issue: 6

ISSN: 0022-1767